Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Martin Feindor"'
Autor:
Martin Feindor, Matthew D. Heath, Simon J. Hewings, Thalia L. Carreno Velazquez, Simon Blank, Johannes Grosch, Thilo Jakob, Peter Schmid-Grendelmeier, Ludger Klimek, David B. K. Golden, Murray A. Skinner, Matthias F. Kramer
Publikováno v:
Toxins, Vol 13, Iss 9, p 616 (2021)
In this review, we outline and reflect on the important differences between allergen-specific immunotherapy for inhalant allergies (i.e., aeroallergens) and venom-specific immunotherapy (VIT), with a special focus on Venomil® Bee and Wasp. Venomil®
Externí odkaz:
https://doaj.org/article/68fad82b24534c588ce4562bee70f883
Autor:
Norbert Pfeiffer, Bogomil Voykov, Giulia Renieri, Katharina Bell, Paul Richter, Melanie Weigel, Hagen Thieme, Barbara Wilhelm, Katrin Lorenz, Martin Feindor, Katja Wosikowski, Michel Janicot, Daniela Päckert, Regina Römmich, Carola Mala, Petra Fettes, Eugen Leo
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188899 (2017)
To evaluate the safety and tolerability of intravitreal ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in patients with primary open angle glaucoma (POAG) undergoing trabeculectomy (TE; glauc
Externí odkaz:
https://doaj.org/article/5b269b6322544aeb927497877deed479
Autor:
Johannes Grosch, Matthew D. Heath, Peter Schmid-Grendelmeier, Simon J Hewings, David B K Golden, Ludger Klimek, Simon Blank, Thilo Jakob, Murray A. Skinner, Thalia L Carreno Velazquez, Martin Feindor, Matthias F. Kramer
Publikováno v:
Toxins, Vol 13, Iss 616, p 616 (2021)
Toxins
Toxins 13:616 (2021)
Toxins
Toxins 13:616 (2021)
In this review, we outline and reflect on the important differences between allergen-specific immunotherapy for inhalant allergies (i.e., aeroallergens) and venom-specific immunotherapy (VIT), with a special focus on Venomil® Bee and Wasp. Venomil®
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22396ab4a4adc7823970bdcee630613d
https://www.mdpi.com/2072-6651/13/9/616
https://www.mdpi.com/2072-6651/13/9/616
Autor:
Martin Feindor, Bogomil Voykov, Melanie Weigel, Katharina Bell, Hagen Thieme, Paul Richter, Katrin Lorenz, Regina Römmich, Michel Janicot, Barbara Wilhelm, Giulia Renieri, Katja Wosikowski, Petra Fettes, Daniela Päckert, Eugen Leo, Carola Mala, Norbert Pfeiffer
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188899 (2017)
PLoS ONE
PLoS ONE
PURPOSE To evaluate the safety and tolerability of intravitreal ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in patients with primary open angle glaucoma (POAG) undergoing trabeculectomy (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07fe8f3eb7a4c6d2b878716b47260b10
http://europepmc.org/articles/PMC5708654?pdf=render
http://europepmc.org/articles/PMC5708654?pdf=render